BridgeBio Pharma revenue and financials
$66.96Change from previous close: +1.24%Absolute change: +$0.82
In the fiscal year ended December 2025, BridgeBio Pharma reported revenue of $502.08M (+126.26% year over year). The net loss was $732.94M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +126.26%
- 2025 vs 2024
- Net margin
- -146.0%
- 2024: -244.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 244 | 195 | 154 | 121 | 111 | 117 | 5.9 | 2.7 | 2.2 | 211 | 1.7 | 4.1 |
| Cost of revenue | 15.0 | 9.9 | 8.1 | 6.6 | 3.7 | 2.6 | 2.1 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
| Gross profit | 229 | 185 | 146 | 114 | 107 | 114 | 3.8 | 2.1 | 1.6 | 211 | 1.1 | 3.5 |
| Selling, general and administrative | 186 | 164 | 158 | 138 | 129 | 106 | 94.8 | 68.8 | 59.5 | 65.8 | 47.6 | 35.8 |
| Research and development | 149 | 127 | 116 | 113 | 111 | 111 | 130 | 120 | 115 | 141 | 130 | 125 |
| Operating income | -107 | -106 | -128 | -136 | -133 | -104 | -221 | -187 | -173 | 3.7 | -177 | -157 |
| EBIT | -107 | -106 | -128 | -136 | -133 | -104 | -221 | -187 | -173 | 3.7 | -177 | -157 |
| EBITDA | -106 | -105 | -127 | -135 | -132 | -103 | -220 | -186 | -171 | 5.3 | -175 | -156 |
| Interest expense | 54.6 | 52.8 | 50.3 | 48.1 | 37.6 | 42.1 | 29.8 | 23.1 | 22.9 | 23.5 | 20.3 | 20.3 |
| Pre-tax income | -156 | -167 | -195 | -186 | -182 | -170 | -266 | -164 | -75.5 | -36.2 | -170 | -179 |
| Income tax | 0.0 | — | -0.1 | -1.5 | 2.1 | — | 1.2 | — | — | — | — | — |
| Net income | -152 | -164 | -193 | -183 | -182 | -167 | -265 | -162 | -73.5 | -35.2 | -168 | -177 |
| Net income to common shareholders | -152 | -164 | -193 | -183 | -182 | -167 | -265 | -162 | -73.5 | -35.2 | -168 | -177 |
| Basic EPS | -0.78 | -0.84 | -1.00 | -0.95 | -0.95 | -0.88 | -1.40 | -0.86 | -0.39 | -0.20 | -0.96 | -1.08 |
| Diluted EPS | -0.78 | -0.84 | -1.00 | -0.95 | -0.95 | -0.88 | -1.40 | -0.86 | -0.39 | -0.20 | -0.96 | -1.08 |
| Average shares (basic) | 196 | 195 | 194 | 192 | 191 | 190 | 189 | 189 | 188 | 179 | 174 | 163 |
| Average shares (diluted) | 196 | 195 | 194 | 192 | 191 | 190 | 189 | 189 | 188 | 179 | 174 | 163 |